BRAVEHEALTH proposes a patient-centric vision to CVD management and treatment, providing people already diagnosed as subjects at risk with a sound solution for continuous and remote monitoring and real time prevention of malignant events. The solution proposed will be made up of the following sub-systems:
1) WEARABLE UNIT: it is an innovative concept of miniaturised multiparameter sensor, able to continuously monitoring the most critical parameters needed to perform a thorough diagnosis by means of specific diagnostic and prognostic algorithms running on it. It will be possible both to perform scheduled analysis of critical parameters and to remotely trigger the screening of specific vital signs.
2) REMOTE MANAGEMENT UNIT: it represents the main interface between physicians and the system, providing both automated support, in the form of text messages with information or suggestions to the patient directly generated by the system, and doctor managed supervision, allowing direct communication with the patients with voice/text/chat messages. The most important added value of the this unit is the possibility to be interfaced with existing National Health Records and Physiological Data Banks in order to generating and verifying risk prediction models using advanced data mining approaches.
3) LIFE! GATEWAY: Data acquired by the wearable unit will be relayed to a gateway which represents the means by which the information flow from the user to the Central Supervision Unit. This unit will provide the user with the following functionalities: 1) Real time communications: in case of anomalies, or simply to suggest specific drugs to be taken, or to advice some particular activity to be performed; 2) Location aware information, exploiting the positioning capabilities of GPS. 3) Mobile virtual community for education and support.
The Telemedicine group research contribution is in the Mobile Virtual Communities.
The Chronic heart diseases patients are usually associated with disease-related problems, for example: insufficient or improper physical exercise, taking medication errors, improper diet and problems for dealing with the disease. Using mobile virtual communities allows patients and professionals to receive and provide assistance for those disease-related problems. Furthermore, the support plays an important role: for some patients information and education are sufficient, but for some patients, other support types are required, such as emotional support or instrumental support. This support is expected to encourage and give a better adaptation of medically necessary lifestyle.
For the validation, a medical trial will be done in Italy and Poland with a total of approximately 500 patients.
Principal Investigator tracks
March 2010 – March 2014